Skip to main content
Premium Trial:

Request an Annual Quote

Claritas Wins $9M Exome Sequencing Contract from VA

NEW YORK (GenomeWeb News) – The US Department of Veterans Affairs has awarded startup clinical diagnostics laboratory Claritas Genomics a $9 million contract to sequence the exomes of veteran samples, Claritas, Life Technologies, and Lockheed Martin announced today.

Exome sequencing performed as part of the contract includes samples from the Million Veteran Program (MVP), which was launched in 2011 to elucidate the genetic underpinnings of health. The contract is for 12 months.

Claritas was spun out of Boston Children's Hospital in February and is based in Cambridge, Mass. It provides genetic testing for hospitals and researchers with a focus on pediatric medicine.

Life Tech supports Claritas with its Ion Proton sequencing technology. Additionally, IT firm Alvarez and Associates provides technical support, while Lockheed Martin provides data security expertise to manage the large amounts of data being generated.

"We know firsthand from our work in pediatrics the power of large datasets to uncover the genetic mechanisms of disease," Patrice Milos, CEO of Claritas, said in a statement. "What's unique about MVP is that we'll produce a massive dataset at a fraction of the time and cost it would have required even a year ago, and that's a direct result of the speed, simplicity, and affordability of Ion Torrent's sequencing technology."

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.